ACLINICAL impression has long been in existence indicating a lesser degree of atherosclerosis in persons with Laennec's cirrhosis. From an analysis of an extensive autopsy experience, Wilens' has presented substantial evidence that there is no significant difference in the extent of atherosclerosis in cirrhotics as compared with other individuals of comparable status and of equivalent age and sex distribution. In view of this controversy it was of interest to investigate in cirrhotics the blood levels of those giant cholesterol bearing lipoproteins, recently shown to be related to atherosclerosis in man.2 The evidence relating such molecules to atherosclerosis involved a demonstration of the occurrence of a higher frequency of elevated levels of Sf 10-20 lipoproteins in patients with myocardial infarcts and in certain diseases predisposing to atherosclerosis (nephrosis, xanthoma tuberosum, diabetes, myxedema).
Thirty-four patients were studied, ranging in age from 17 to 72 years, including both males and females. The blood serum was analyzed for lipoproteins of the Sf 10-20 class ultracentrifugally by the technic described.2'3 25 levels in clinically normal individuals of comparable age and sex distribution. It is evident that cirrhotics have at least as high, and possibly even higher levels of the Sf 10-20 class of molecules as do clinically normal individuals of corresponding age and sex. However, the difference between these two groups is not significant so no further refinement can be obtained from the data of figure 1. No correlation between the levels of the St 10-20 class of molecules and any of the clinical or laboratory findings recorded in table 1 coult be established.
It is of interest that both of 2 male patients, 17 and 21 years of age, in the active phase of infectious hepatitis showed very high levels of Sf 10-20 lipoproteins. This is in contrAst to the rarity of such high levels in normals of this same age group. While this may indicate a disturbance of lipoprotein metabolism during acute parenchymal liver disease, a larger series must be studied to establish the significance of this observation.
Since the level of the Sf 10-20 class of molecule has been correlated with atherosclerosis and since the level of such molecules is not significantly different in patients with chronic hepatitis as compared with "normals," one would anticipate that such patients might show the same degree of atherosclerosis as found in the general population. These findings would support Wilen's observations indicating that patients with chronic hepatitis are not protected against atherosclerosis. Preliminary data indicate elevated Sf 10-20 levels in the active phase of acute hepatitis.
